FDA fast-tracks topical drops for LHON
- Posted on: Dec 19 2017
- Leave a response
Stealth BioTherapeutics has gained the fast-track designation for elamipretide, an eye drop aimed at improving mitochondrial function in individuals with Leber’s hereditary optic neuropathy (LHON).
Source: AAO
Posted in: Uncategorized